Friday, January 13, 2017

My Alerts: vincents blog news (1 article)

Add nytdirect@nytimes.com to your address book.
To edit or delete this email alert, please go to Manage My Alerts.
Representatives Chris Collins and Tom Price and other power players have substantial investments in Innate Immunotherapeutics, a company with no approved drugs.
Peter Prato for The New York Times
Australian Drug Maker Has Low Profile but Powerful Backers in Washington

Representatives Chris Collins and Tom Price and other power players have substantial investments in Innate Immunotherapeutics, a company with no approved drugs.

ADVERTISEMENT
Get unlimited access to NYTimes.com and our NYTimes apps for just $0.99. Subscribe »